Could a gut bug boost Crohn's treatment? new trial investigates
NCT ID NCT07415473
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a specific gut bacteria (Akkermansia muciniphila) to the standard drug infliximab helps heal the intestinal lining better than infliximab alone in people with Crohn's disease. About 400 adults with active Crohn's will be randomly assigned to one of two groups. The goal is to see if the combination leads to more complete healing of gut ulcers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.